HomeRXK3 • FRA
add
Sellas Life Sciences Group Inc
Previous close
€1.80
Day range
€1.65 - €1.65
Year range
€0.80 - €2.60
Market cap
191.64M USD
Avg Volume
1.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.87M | -9.81% |
Net income | -6.60M | 11.63% |
Net profit margin | — | — |
Earnings per share | -0.07 | 46.15% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.30M | 176.56% |
Total assets | 32.30M | 113.67% |
Total liabilities | 6.16M | -49.57% |
Total equity | 26.15M | — |
Shares outstanding | 105.30M | — |
Price to book | 6.92 | — |
Return on assets | -51.09% | — |
Return on capital | -61.90% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.60M | 11.63% |
Cash from operations | -7.33M | 24.29% |
Cash from investing | — | — |
Cash from financing | 4.23M | 921.74% |
Net change in cash | -3.10M | 66.55% |
Free cash flow | -5.28M | 23.89% |
About
Founded
2006
Website
Employees
15
